annual cash & cash equivalents:
$77.39M-$92.81M(-54.53%)Summary
- As of today (September 18, 2025), AMLX annual cash & cash equivalents is $77.39 million, with the most recent change of -$92.81 million (-54.53%) on December 31, 2024.
- During the last 3 years, AMLX annual cash & cash equivalents has risen by +$27.20 million (+54.19%).
- AMLX annual cash & cash equivalents is now -54.53% below its all-time high of $170.20 million, reached on December 31, 2023.
Performance
AMLX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$180.83M-$23.24M(-11.39%)Summary
- As of today (September 18, 2025), AMLX quarterly cash & cash equivalents is $180.83 million, with the most recent change of -$23.24 million (-11.39%) on June 1, 2025.
- Over the past year, AMLX quarterly cash & cash equivalents has dropped by -$128.99 million (-41.63%).
- AMLX quarterly cash & cash equivalents is now -51.56% below its all-time high of $373.29 million, reached on March 31, 2024.
Performance
AMLX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AMLX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -54.5% | -41.6% |
| 3 y3 years | +54.2% | -12.5% |
| 5 y5 years | +2425.0% | +1304.3% |
AMLX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.5% | +54.2% | -51.6% | +11.2% |
| 5 y | 5-year | -54.5% | +2425.0% | -51.6% | +1304.3% |
| alltime | all time | -54.5% | +2425.0% | -51.6% | +1304.3% |
AMLX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $180.83M(-11.4%) |
| Mar 2025 | - | $204.07M(+15.6%) |
| Dec 2024 | $77.39M(-54.5%) | $176.50M(-24.7%) |
| Sep 2024 | - | $234.40M(-24.3%) |
| Jun 2024 | - | $309.81M(-17.0%) |
| Mar 2024 | - | $373.29M(+0.5%) |
| Dec 2023 | $170.20M | $371.36M(+4.6%) |
| Sep 2023 | - | $355.05M(-0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $357.28M(+3.4%) |
| Mar 2023 | - | $345.67M(-0.4%) |
| Dec 2022 | $62.53M(+24.6%) | $346.94M(+113.4%) |
| Sep 2022 | - | $162.59M(-21.3%) |
| Jun 2022 | - | $206.68M(-19.0%) |
| Mar 2022 | - | $255.21M(+165.5%) |
| Dec 2021 | $50.19M(+289.8%) | $96.12M(+646.4%) |
| Dec 2020 | $12.88M(+320.1%) | $12.88M |
| Dec 2019 | $3.06M | - |
FAQ
- What is Amylyx Pharmaceuticals, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
What is Amylyx Pharmaceuticals, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of AMLX is $77.39M
What is the all time high annual cash & cash equivalents for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $170.20M
What is Amylyx Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, AMLX annual cash & cash equivalents has changed by -$92.81M (-54.53%)
What is Amylyx Pharmaceuticals, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of AMLX is $180.83M
What is the all time high quarterly cash & cash equivalents for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $373.29M
What is Amylyx Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, AMLX quarterly cash & cash equivalents has changed by -$128.99M (-41.63%)